A prospective, multicenter study of enrolled patients and to identify any associations with specific inflammatory conditions of the pouch
Latest Information Update: 06 Jul 2021
At a glance
- Drugs Adalimumab (Primary) ; Aminosalicylic acid (Primary) ; Azathioprine (Primary) ; Certolizumab pegol (Primary) ; Infliximab (Primary) ; Mercaptopurine (Primary) ; Probiotics (Primary) ; Steroids (Primary) ; Tofacitinib (Primary) ; Tumour necrosis factor alpha modulators (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Pouchitis
- Focus Adverse reactions
Most Recent Events
- 05 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021.